US Patent Issued to KAHR Medical on June 17 for "SIRPalpha-41BBL fusion protein and methods of use thereof" (Israeli, Dutch Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,098, issued on June 17, was assigned to KAHR Medical Ltd. (Modiln Makabim-ReUt, Israel).

"SIRPalpha-41BBL fusion protein and methods of use thereof" was invented by Noam Shani (Zikhron-Yaakov, Israel), Yosi Gozlan (Rehovot, Israel), Michal Dranitzki Elhalel (Shoresh, Israel), Edwin Bremer (Groningen, Netherlands) and Ido Kaminsky (Ramat-Gan, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "SIRP1alpha-41BBL fusion proteins are provided. Accordingly, there is provided a SIRPalpha-41BBL fusion protein comprising a single amino acid linker between the SIRPalpha and the 41BBL. Also there is provided a SIRPalpha-41BBL fusion protein in a form of at l...